Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

Affiliations

• ¹ Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan. yanagi-tky@umin.ac.jp.
• ² Department of Ophthalmology, Kansai Medical University, Osaka, Japan.
• ³ Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
• ⁴ Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan.
• ⁵ IQVIA Solutions Japan, K.K., Tokyo, Japan.
• ⁶ Senju Pharmaceutical Co., Ltd., Osaka, Japan.
• ⁷ Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.